WALSX vs. BIVIX

Last updated Apr 1, 2026

Compare and contrast key facts about Wasatch Long/Short Alpha Fund (WALSX) and Invenomic Fund Institutional Class (BIVIX).

WALSX is managed by Wasatch. It was launched on Sep 30, 2021. BIVIX is an actively managed fund by Invenomic. It was launched on Jun 19, 2017.

Performance

WALSX vs. BIVIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Wasatch Long/Short Alpha Fund (WALSX) and Invenomic Fund Institutional Class (BIVIX). The values are adjusted to include any dividend payments, if applicable.

WALSX vs. BIVIX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
WALSX Wasatch Long/Short Alpha Fund	1.55%	-12.79%	7.24%	27.75%	-8.38%	12.20%
BIVIX Invenomic Fund Institutional Class	6.05%	4.63%	-8.81%	16.80%	50.01%	14.68%

Returns By Period

In the year-to-date period, WALSX achieves a 1.55% return, which is significantly lower than BIVIX's 6.05% return.

WALSX

• 1D: -0.72%
• 1M: -8.45%
• YTD: 1.55%
• 6M: -0.56%
• 1Y: -7.36%
• 3Y*: 5.14%
• 5Y*: —
• 10Y*: —

BIVIX

• 1D: 3.47%
• 1M: 2.62%
• YTD: 6.05%
• 6M: 11.34%
• 1Y: 7.17%
• 3Y*: 1.96%
• 5Y*: 17.01%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

WALSX vs. BIVIX - Expense Ratio Comparison

WALSX has a 1.75% expense ratio, which is lower than BIVIX's 3.17% expense ratio.

BIVIX

Invenomic Fund Institutional Class

WALSX

Wasatch Long/Short Alpha Fund

Return for Risk

WALSX vs. BIVIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

WALSX

WALSX Risk / Return Rank: 2
WALSX Sharpe Ratio Rank: 2
WALSX Sortino Ratio Rank: 2
WALSX Omega Ratio Rank: 2
WALSX Calmar Ratio Rank: 1
WALSX Martin Ratio Rank: 2

BIVIX

BIVIX Risk / Return Rank: 13
BIVIX Sharpe Ratio Rank: 12
BIVIX Sortino Ratio Rank: 14
BIVIX Omega Ratio Rank: 10
BIVIX Calmar Ratio Rank: 15
BIVIX Martin Ratio Rank: 12

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

WALSX vs. BIVIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Wasatch Long/Short Alpha Fund (WALSX) and Invenomic Fund Institutional Class (BIVIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	WALSX	BIVIX	Difference
Sharpe ratio Return per unit of total volatility	-0.40	0.33	-0.74
Sortino ratio Return per unit of downside risk	-0.48	0.67	-1.15
Omega ratio Gain probability vs. loss probability	0.94	1.07	-0.13
Calmar ratio Return relative to maximum drawdown	-0.57	0.44	-1.02
Martin ratio Return relative to average drawdown	-1.06	0.99	-2.05
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

WALSX vs. BIVIX - Sharpe Ratio Comparison

The current WALSX Sharpe Ratio is -0.40, which is lower than the BIVIX Sharpe Ratio of 0.33. The chart below compares the historical Sharpe Ratios of WALSX and BIVIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	WALSX	BIVIX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.40	0.33	-0.74
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	1.07	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.31	1.05	-0.74

Correlation

The correlation between WALSX and BIVIX is 0.05, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

WALSX vs. BIVIX - Dividend Comparison

WALSX has not paid dividends to shareholders, while BIVIX's dividend yield for the trailing twelve months is around 2.07%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
WALSX Wasatch Long/Short Alpha Fund	0.00%	0.00%	0.00%	0.00%	0.09%	0.00%	0.00%	0.00%	0.00%	0.00%
BIVIX Invenomic Fund Institutional Class	2.07%	2.20%	3.95%	20.15%	27.91%	16.08%	3.15%	3.19%	4.79%	1.21%

Drawdowns

WALSX vs. BIVIX - Drawdown Comparison

The maximum WALSX drawdown since its inception was -25.28%, which is greater than BIVIX's maximum drawdown of -18.32%. Use the drawdown chart below to compare losses from any high point for WALSX and BIVIX.

Drawdown Indicators

	WALSX	BIVIX	Difference
Max Drawdown Largest peak-to-trough decline	-25.28%	-18.32%	-6.96%
Max Drawdown (1Y) Largest decline over 1 year	-14.71%	-13.71%	-1.00%
Max Drawdown (5Y) Largest decline over 5 years	—	-17.23%	—
Current Drawdown Current decline from peak	-22.03%	-0.64%	-21.39%
Average Drawdown Average peak-to-trough decline	-9.16%	-5.75%	-3.41%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.97%	6.10%	+1.87%

Volatility

WALSX vs. BIVIX - Volatility Comparison

The current volatility for Wasatch Long/Short Alpha Fund (WALSX) is 5.19%, while Invenomic Fund Institutional Class (BIVIX) has a volatility of 7.63%. This indicates that WALSX experiences smaller price fluctuations and is considered to be less risky than BIVIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	WALSX	BIVIX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.19%	7.63%	-2.44%
Volatility (6M) Calculated over the trailing 6-month period	11.06%	16.63%	-5.57%
Volatility (1Y) Calculated over the trailing 1-year period	17.77%	20.71%	-2.94%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.30%	16.09%	+0.21%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.30%	16.60%	-0.30%